Anti-Transcriptional Intermediary Factor 1-gamma Antibodies in Dermatomyositis with and Without Cancer - A Longitudinal Study

被引：0
|
作者：
Dani, Lara [1 ,2 ]
Selickaja, Sandra [3 ,4 ]
Galindo-Feria, Angeles Shunashy [5 ]
Svensson, John [1 ]
Venalis, Paulius [6 ]
Leonard, Dag [7 ]
Hemberg, Malin [8 ]
Hanna, Balsam [9 ]
Lundberg, Ingrid E. [10 ]
Holmqvist, Marie [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] State Res Inst Innovat Med, Vilnius, Lithuania
[4] Vilnius Univ Hosp, Santaros Klin, Vilnius, Lithuania
[5] Karolinska Inst, Karolinska Univ Hosp, Stockholm, Sweden
[6] Karolinska Inst, Dept Med, Ctr Mol Med, Stockholm, Sweden
[7] Uppsala Univ, Dept Rheumatol, Uppsala, Sweden
[8] Falu Lasarett, Rheumatol Unit, Falun, Sweden
[9] Sahlgrens Univ Hosp, Dept Rheumatol, Gothenburg, Sweden
[10] Karolinska Inst, Karolinska Univ Hosp, Div Rheumatol, Dept Med Solna, Stockholm, Sweden
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0696
引用
收藏
页码：1412 / 1413
页数：2
相关论文
共 50 条
  • [31] Clinical significance of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis: a monocentric cross-sectional study
    Huanhuan Yang
    Tingting Yan
    Xin Zhang
    Wenjia Sun
    Lei Liu
    Yan Du
    Jing Xue
    Clinical Rheumatology, 2022, 41 : 2439 - 2448
  • [32] Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer
    Yuki Sato
    Yoshinori Tanino
    Takefumi Nikaido
    Ryuichi Togawa
    Takaya Kawamata
    Natsumi Watanabe
    Riko Sato
    Ryuki Yamada
    Takumi Onuma
    Hikaru Tomita
    Mikako Saito
    Mami Rikimaru
    Julia Morimoto
    Yasuhito Suzuki
    Hiroyuki Minemura
    Junpei Saito
    Kenya Kanazawa
    Syoki Yamada
    Yuko Hashimoto
    Yoko Shibata
    BMC Pulmonary Medicine, 22
  • [33] Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer
    Sato, Yuki
    Tanino, Yoshinori
    Nikaido, Takefumi
    Togawa, Ryuichi
    Kawamata, Takaya
    Watanabe, Natsumi
    Sato, Riko
    Yamada, Ryuki
    Onuma, Takumi
    Tomita, Hikaru
    Saito, Mikako
    Rikimaru, Mami
    Morimoto, Julia
    Suzuki, Yasuhito
    Minemura, Hiroyuki
    Saito, Junpei
    Kanazawa, Kenya
    Yamada, Syoki
    Hashimoto, Yuko
    Shibata, Yoko
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [34] The Role of Transcriptional Intermediary Factor 1-gamma (TIF1γ), a Dermatomyositis Associated Autoantigen, in Muscle Fiber Differentiation and Regeneration
    Mohassel, Payam
    Rosen, Paul
    Mammen, Andrew
    NEUROLOGY, 2013, 80
  • [35] Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy
    Aritomi, Takafumi
    Kido, Takashi
    Nakano, Kazuhisa
    Satoh, Yurie
    Noguchi, Shingo
    Jotatsu, Takanobu
    Hanaka, Tetsuya
    Satoh, Minoru
    Tanaka, Yoshiya
    Yatera, Kazuhiro
    INTERNAL MEDICINE, 2019, 58 (03) : 427 - 431
  • [36] Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis: Reply
    Oldroyd, Alexander
    Sergeant, Jamie C.
    New, R. Paul
    McHugh, Neil J.
    Betteridge, Zoe
    Lamb, Janine A.
    Ollier, William E.
    Cooper, Robert G.
    Chinoy, Hector
    RHEUMATOLOGY, 2019, 58 (11) : 2073 - 2074
  • [37] Association of Anti-CCAR1 Autoantibodies With Decreased Cancer Risk Relative to the General Population in Patients With Anti-Transcriptional Intermediary Factor 1γ-Positive Dermatomyositis
    Fiorentino, David
    Mecoli, Christopher A.
    Igusa, Tak
    Albayda, Jemima
    Paik, Julie J.
    Tiniakou, Eleni
    Adler, Brittany
    Mammen, Andrew L.
    Shah, Ami A.
    Rosen, Antony
    Christopher-Stine, Lisa
    Casciola-Rosen, Livia
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (07) : 1238 - 1245
  • [38] A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients
    Sumazaki, Makoto
    Kaneko, Kaichi
    Ito, Masaaki
    Oshima, Yoko
    Saito, Fumi
    Ogata, Hideaki
    Shibuya, Kazutoshi
    Shimada, Hideaki
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 5
  • [39] Anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report
    Megumu Osaki
    Ryo Tachikawa
    Junichiro Ohira
    Shigeo Hara
    Keisuke Tomii
    Investigational New Drugs, 2021, 39 : 251 - 255
  • [40] Anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report
    Osaki, Megumu
    Tachikawa, Ryo
    Ohira, Junichiro
    Hara, Shigeo
    Tomii, Keisuke
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (01) : 251 - 255
12345